Bibliography
- YANGISAWA M, KURIHARA H, KIMURA S et al: A novelpotent constrictor peptide produced by vascular endo-thelial cells. Nature (1988) 332:411–415.
- NOLL G, WENZEL RR, LUESCHER TF: Endothelin andendothelin antagonists: potential role in cardiovascular and renal disease. Mol Cell. Biochem. (1996) 157(1&2):259–267.
- GRAY GA, WEBB DJ: The endothelin system and itspotential as a therapeutic target in cardiovascular dis-ease. Pharmacol. Ther. (1996) 72(2):109–148.
- SHIMADA K, MATSUSHITA Y, WAKABAYASHI K et al: Cloning and functional expression of human en-dothelin-converting enzyme cDNA. Biochem. Biophys. Res. Commun. (1995) 207:807–812.
- EMOTO N, YANAGISAWA M: Endothelin-converting en-zyme-2 is a membrane-bound, phosphoramidon-se ns five metalloprotease with acidic pH optimum. J. Biochem. (1995) 270:15262–15268.
- GELLAI M, JUGAS M, FLETCHER T et al: Nonpeptide endothelin receptor antagonists. V. Prevention and reversal ofacute renal failure in the rat by SB 209670. Pharmacol. Exp. Ther. (1995) 275(0:200–206.
- BARONE FC, WILLETTE RN, YUE T-L, FEURESTEIN G:Therapeutic effects of endothelin receptor antagonists in stroke. Neurol Res (1995) 17(4):259–264.
- PATEL TR, GALBRAITH DI, HALLAK H et al: Endothelinreceptor antagonist increases cerebral perfusion and reduces ischemic damage in feline focal cerebral is-chemia. j Cereb. Blood FlowMetab. (1996) 16(5):950–958.
- GURBANOV K, RUBENSTEIN I, HOFFMAN A et al: Bosen-tan improves renal blood flow in rats with experimen-tal heart failure. Eur. J. Pharmacol. (1996) 310(2/3):193–196.
- MATSUMURA Y, HISAKI K, TAKAOKA M, MORIMOTO S:Phosphoramidon, a metalloprotease inhibitor, sup-presses the hypertensive effect of big endothelin-1. Eur. Pharmacol. (1990) 185:103–106.
- CHACKALAMANNIL S CHUNG S, STAMFORD AW et al:Highly potent and selective inhibitors of endothelin converting enzyme. Bioorg. Med. Chem. Lett. (1996) 6(1 0 :1257–1260.
- TSURUMI Y, UEDA H, HAYASHI K eta].: W575624 A andB, new endothelin converting enzyme inhibitors iso-lated from Saccharothrix sp. No. 75624. 1. Taxonomy, fermentation, isolation, physico-chemical properties and biologicals activities. J. Ant/blot. (1995) 48(10): 1066–1072.
- KUKKOLA PJ, BILCI NA KOZAK WX, SAVAGE P, JENG AY: Optimisation of retrothiorphan for inhibition of en-dothelin converting enzyme. Bioorg. Med. Chem. Lett. (1996) 6(6):619–624.
- DEPREZ P, GUILLAUME J, DUMAS J, VEVERT J-P: Thiol inhibitors of endothelin converting enzyme. Bioorg. Med. Chem. Lett. (1996) 6(19):2317–2322.
- DE LOMBAERT S, GHAI RD, JENG AY, TRAPANI AJ, WEBB RL: Pharmacological profile of a non-peptidic dual in-hibitor of neutral endopeptidase 24.11 and endothelin converting enzyme. Biochem. Biophys. Res. Commun. (1994) 204(10):407–412.